問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
賴彬卿
下載
2023-06-30 - 2030-12-31
Condition/Disease
Test Drug
Participate Sites7Sites
Recruiting7Sites
2023-11-01 - 2027-12-31
Participate Sites6Sites
Not yet recruiting5Sites
Recruiting1Sites
2018-10-01 - 2022-06-30
Participate Sites12Sites
Recruiting11Sites
2021-03-19 - 2025-07-15
Participate Sites5Sites
Recruiting5Sites
2021-07-15 - 2026-12-31
Participate Sites2Sites
Recruiting2Sites
2021-10-01 - 2029-04-30
2021-02-01 - 2025-12-31
Recruiting6Sites
2022-01-05 - 2026-09-19
Participate Sites9Sites
Not yet recruiting1Sites
Recruiting8Sites
2024-12-16 - 2029-12-31
Participate Sites4Sites
Recruiting4Sites
2024-07-01 - 2027-12-31
chronic kidney disease
placebo ‧ BI 690517 Empagliflozin
Participate Sites23Sites
Recruiting23Sites
全部
